nodes	percent_of_prediction	percent_of_DWPC	metapath
SIMEPREVIR—ABCB1—ovarian cancer	0.486	1	CbGaD
SIMEPREVIR—ABCB1—Topotecan—ovarian cancer	0.0721	0.221	CbGbCtD
SIMEPREVIR—ABCB1—Vinorelbine—ovarian cancer	0.0508	0.156	CbGbCtD
SIMEPREVIR—CYP3A4—Topotecan—ovarian cancer	0.0432	0.133	CbGbCtD
SIMEPREVIR—ABCB1—Paclitaxel—ovarian cancer	0.0357	0.11	CbGbCtD
SIMEPREVIR—CYP3A4—Vinorelbine—ovarian cancer	0.0304	0.0935	CbGbCtD
SIMEPREVIR—ABCB1—Docetaxel—ovarian cancer	0.0258	0.0792	CbGbCtD
SIMEPREVIR—CYP3A4—Paclitaxel—ovarian cancer	0.0214	0.0657	CbGbCtD
SIMEPREVIR—ABCB1—Doxorubicin—ovarian cancer	0.0192	0.0591	CbGbCtD
SIMEPREVIR—CYP3A4—Docetaxel—ovarian cancer	0.0155	0.0475	CbGbCtD
SIMEPREVIR—CYP3A4—Doxorubicin—ovarian cancer	0.0115	0.0354	CbGbCtD
SIMEPREVIR—CTSS—myometrium—ovarian cancer	0.00476	0.0903	CbGeAlD
SIMEPREVIR—CTSS—embryo—ovarian cancer	0.00458	0.0869	CbGeAlD
SIMEPREVIR—CTSS—uterine cervix—ovarian cancer	0.0037	0.0703	CbGeAlD
SIMEPREVIR—CTSS—decidua—ovarian cancer	0.00353	0.067	CbGeAlD
SIMEPREVIR—Anaemia—Altretamine—ovarian cancer	0.00353	0.0311	CcSEcCtD
SIMEPREVIR—CTSS—endometrium—ovarian cancer	0.00335	0.0636	CbGeAlD
SIMEPREVIR—CTSS—gonad—ovarian cancer	0.00311	0.059	CbGeAlD
SIMEPREVIR—CTSS—uterus—ovarian cancer	0.00309	0.0586	CbGeAlD
SIMEPREVIR—Hyperbilirubinaemia—Topotecan—ovarian cancer	0.00304	0.0268	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Topotecan—ovarian cancer	0.00292	0.0258	CcSEcCtD
SIMEPREVIR—CTSS—female reproductive system—ovarian cancer	0.00278	0.0527	CbGeAlD
SIMEPREVIR—Fatigue—Altretamine—ovarian cancer	0.00269	0.0237	CcSEcCtD
SIMEPREVIR—CTSS—bone marrow—ovarian cancer	0.00262	0.0497	CbGeAlD
SIMEPREVIR—CTSS—female gonad—ovarian cancer	0.00253	0.0479	CbGeAlD
SIMEPREVIR—CTSS—vagina—ovarian cancer	0.00251	0.0476	CbGeAlD
SIMEPREVIR—Blood bilirubin increased—Vinorelbine—ovarian cancer	0.0025	0.022	CcSEcCtD
SIMEPREVIR—CTSS—testis—ovarian cancer	0.00224	0.0425	CbGeAlD
SIMEPREVIR—Asthenia—Altretamine—ovarian cancer	0.00224	0.0197	CcSEcCtD
SIMEPREVIR—Infection—Carboplatin—ovarian cancer	0.00214	0.0189	CcSEcCtD
SIMEPREVIR—Nausea—Altretamine—ovarian cancer	0.00185	0.0163	CcSEcCtD
SIMEPREVIR—SLCO1B1—female reproductive system—ovarian cancer	0.0018	0.0341	CbGeAlD
SIMEPREVIR—Hyperbilirubinaemia—Paclitaxel—ovarian cancer	0.00175	0.0154	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Paclitaxel—ovarian cancer	0.00168	0.0148	CcSEcCtD
SIMEPREVIR—CTSS—lymph node—ovarian cancer	0.00162	0.0308	CbGeAlD
SIMEPREVIR—Hyperbilirubinaemia—Docetaxel—ovarian cancer	0.00148	0.0131	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Topotecan—ovarian cancer	0.00146	0.0129	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Melphalan—ovarian cancer	0.00143	0.0126	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Docetaxel—ovarian cancer	0.00142	0.0126	CcSEcCtD
SIMEPREVIR—Anaemia—Chlorambucil—ovarian cancer	0.00125	0.0111	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Topotecan—ovarian cancer	0.00125	0.011	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Vinorelbine—ovarian cancer	0.00125	0.011	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Melphalan—ovarian cancer	0.00122	0.0108	CcSEcCtD
SIMEPREVIR—ALB—testis—ovarian cancer	0.00117	0.0222	CbGeAlD
SIMEPREVIR—Anaemia—Topotecan—ovarian cancer	0.00112	0.00985	CcSEcCtD
SIMEPREVIR—Infection—Chlorambucil—ovarian cancer	0.0011	0.0097	CcSEcCtD
SIMEPREVIR—Anaemia—Melphalan—ovarian cancer	0.00109	0.00964	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00107	0.00943	CcSEcCtD
SIMEPREVIR—Myalgia—Topotecan—ovarian cancer	0.00103	0.00907	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00102	0.00901	CcSEcCtD
SIMEPREVIR—Myalgia—Melphalan—ovarian cancer	0.00101	0.00888	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.001	0.00882	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Epirubicin—ovarian cancer	0.001	0.00882	CcSEcCtD
SIMEPREVIR—Infection—Topotecan—ovarian cancer	0.00098	0.00864	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Epirubicin—ovarian cancer	0.000961	0.00848	CcSEcCtD
SIMEPREVIR—Infection—Melphalan—ovarian cancer	0.000959	0.00846	CcSEcCtD
SIMEPREVIR—Skin disorder—Topotecan—ovarian cancer	0.000958	0.00844	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000956	0.00843	CcSEcCtD
SIMEPREVIR—Anaemia—Vinorelbine—ovarian cancer	0.000955	0.00842	CcSEcCtD
SIMEPREVIR—Fatigue—Chlorambucil—ovarian cancer	0.000955	0.00842	CcSEcCtD
SIMEPREVIR—Skin disorder—Melphalan—ovarian cancer	0.000938	0.00827	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Doxorubicin—ovarian cancer	0.000925	0.00816	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.000911	0.00803	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000898	0.00792	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Doxorubicin—ovarian cancer	0.000889	0.00784	CcSEcCtD
SIMEPREVIR—Myalgia—Vinorelbine—ovarian cancer	0.00088	0.00776	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00088	0.00776	CcSEcCtD
SIMEPREVIR—Dyspnoea—Topotecan—ovarian cancer	0.000879	0.00775	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000874	0.0077	CcSEcCtD
SIMEPREVIR—Dyspnoea—Melphalan—ovarian cancer	0.000861	0.00759	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000851	0.00751	CcSEcCtD
SIMEPREVIR—Fatigue—Topotecan—ovarian cancer	0.00085	0.0075	CcSEcCtD
SIMEPREVIR—ALB—lymph node—ovarian cancer	0.00085	0.0161	CbGeAlD
SIMEPREVIR—Constipation—Topotecan—ovarian cancer	0.000843	0.00743	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000841	0.00742	CcSEcCtD
SIMEPREVIR—ABCB1—myometrium—ovarian cancer	0.00084	0.0159	CbGeAlD
SIMEPREVIR—Infection—Vinorelbine—ovarian cancer	0.000838	0.00739	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000833	0.00735	CcSEcCtD
SIMEPREVIR—Fatigue—Melphalan—ovarian cancer	0.000832	0.00734	CcSEcCtD
SIMEPREVIR—Skin disorder—Vinorelbine—ovarian cancer	0.000819	0.00722	CcSEcCtD
SIMEPREVIR—ABCB1—embryo—ovarian cancer	0.000808	0.0153	CbGeAlD
SIMEPREVIR—Asthenia—Chlorambucil—ovarian cancer	0.000795	0.00701	CcSEcCtD
SIMEPREVIR—Pruritus—Chlorambucil—ovarian cancer	0.000784	0.00691	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000768	0.00678	CcSEcCtD
SIMEPREVIR—Dyspnoea—Vinorelbine—ovarian cancer	0.000752	0.00663	CcSEcCtD
SIMEPREVIR—Photosensitivity—Epirubicin—ovarian cancer	0.000752	0.00663	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000728	0.00642	CcSEcCtD
SIMEPREVIR—Fatigue—Vinorelbine—ovarian cancer	0.000727	0.00641	CcSEcCtD
SIMEPREVIR—Constipation—Vinorelbine—ovarian cancer	0.000721	0.00636	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00072	0.00635	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000713	0.00629	CcSEcCtD
SIMEPREVIR—Asthenia—Topotecan—ovarian cancer	0.000707	0.00624	CcSEcCtD
SIMEPREVIR—Pruritus—Topotecan—ovarian cancer	0.000698	0.00615	CcSEcCtD
SIMEPREVIR—Photosensitivity—Doxorubicin—ovarian cancer	0.000695	0.00613	CcSEcCtD
SIMEPREVIR—Asthenia—Melphalan—ovarian cancer	0.000693	0.00611	CcSEcCtD
SIMEPREVIR—CYP3A4—female reproductive system—ovarian cancer	0.000692	0.0131	CbGeAlD
SIMEPREVIR—Pruritus—Melphalan—ovarian cancer	0.000683	0.00602	CcSEcCtD
SIMEPREVIR—ABCB1—epithelium—ovarian cancer	0.000659	0.0125	CbGeAlD
SIMEPREVIR—Nausea—Chlorambucil—ovarian cancer	0.000658	0.0058	CcSEcCtD
SIMEPREVIR—ABCB1—uterine cervix—ovarian cancer	0.000653	0.0124	CbGeAlD
SIMEPREVIR—Anaemia—Paclitaxel—ovarian cancer	0.000642	0.00567	CcSEcCtD
SIMEPREVIR—ABCB1—decidua—ovarian cancer	0.000623	0.0118	CbGeAlD
SIMEPREVIR—Rash—Topotecan—ovarian cancer	0.000622	0.00548	CcSEcCtD
SIMEPREVIR—Dermatitis—Topotecan—ovarian cancer	0.000621	0.00548	CcSEcCtD
SIMEPREVIR—Headache—Topotecan—ovarian cancer	0.000618	0.00545	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Docetaxel—ovarian cancer	0.00061	0.00538	CcSEcCtD
SIMEPREVIR—Rash—Melphalan—ovarian cancer	0.000609	0.00537	CcSEcCtD
SIMEPREVIR—Dermatitis—Melphalan—ovarian cancer	0.000608	0.00536	CcSEcCtD
SIMEPREVIR—Asthenia—Vinorelbine—ovarian cancer	0.000605	0.00534	CcSEcCtD
SIMEPREVIR—Pruritus—Vinorelbine—ovarian cancer	0.000597	0.00526	CcSEcCtD
SIMEPREVIR—Myalgia—Paclitaxel—ovarian cancer	0.000592	0.00522	CcSEcCtD
SIMEPREVIR—ABCB1—endometrium—ovarian cancer	0.000591	0.0112	CbGeAlD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000588	0.00518	CcSEcCtD
SIMEPREVIR—Nausea—Topotecan—ovarian cancer	0.000586	0.00516	CcSEcCtD
SIMEPREVIR—Nausea—Melphalan—ovarian cancer	0.000573	0.00506	CcSEcCtD
SIMEPREVIR—Infection—Paclitaxel—ovarian cancer	0.000564	0.00497	CcSEcCtD
SIMEPREVIR—Skin disorder—Paclitaxel—ovarian cancer	0.000551	0.00486	CcSEcCtD
SIMEPREVIR—ABCB1—gonad—ovarian cancer	0.000548	0.0104	CbGeAlD
SIMEPREVIR—ABCB1—uterus—ovarian cancer	0.000545	0.0103	CbGeAlD
SIMEPREVIR—Anaemia—Docetaxel—ovarian cancer	0.000545	0.0048	CcSEcCtD
SIMEPREVIR—Rash—Vinorelbine—ovarian cancer	0.000532	0.00469	CcSEcCtD
SIMEPREVIR—Dermatitis—Vinorelbine—ovarian cancer	0.000531	0.00469	CcSEcCtD
SIMEPREVIR—Headache—Vinorelbine—ovarian cancer	0.000528	0.00466	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000521	0.00459	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000517	0.00456	CcSEcCtD
SIMEPREVIR—Insomnia—Paclitaxel—ovarian cancer	0.000513	0.00452	CcSEcCtD
SIMEPREVIR—Dyspnoea—Paclitaxel—ovarian cancer	0.000506	0.00446	CcSEcCtD
SIMEPREVIR—Myalgia—Docetaxel—ovarian cancer	0.000502	0.00442	CcSEcCtD
SIMEPREVIR—Nausea—Vinorelbine—ovarian cancer	0.000501	0.00442	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000498	0.00439	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00049	0.00432	CcSEcCtD
SIMEPREVIR—ABCB1—female reproductive system—ovarian cancer	0.00049	0.00929	CbGeAlD
SIMEPREVIR—Fatigue—Paclitaxel—ovarian cancer	0.000489	0.00431	CcSEcCtD
SIMEPREVIR—Constipation—Paclitaxel—ovarian cancer	0.000485	0.00428	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000482	0.00425	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000481	0.00424	CcSEcCtD
SIMEPREVIR—Infection—Docetaxel—ovarian cancer	0.000478	0.00421	CcSEcCtD
SIMEPREVIR—Skin disorder—Docetaxel—ovarian cancer	0.000467	0.00412	CcSEcCtD
SIMEPREVIR—ABCB1—bone marrow—ovarian cancer	0.000462	0.00877	CbGeAlD
SIMEPREVIR—ABCB1—female gonad—ovarian cancer	0.000446	0.00845	CbGeAlD
SIMEPREVIR—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000445	0.00392	CcSEcCtD
SIMEPREVIR—ABCB1—vagina—ovarian cancer	0.000443	0.0084	CbGeAlD
SIMEPREVIR—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000438	0.00386	CcSEcCtD
SIMEPREVIR—Insomnia—Docetaxel—ovarian cancer	0.000435	0.00384	CcSEcCtD
SIMEPREVIR—Dyspnoea—Docetaxel—ovarian cancer	0.000429	0.00378	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000415	0.00366	CcSEcCtD
SIMEPREVIR—Fatigue—Docetaxel—ovarian cancer	0.000415	0.00366	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Epirubicin—ovarian cancer	0.000411	0.00363	CcSEcCtD
SIMEPREVIR—Constipation—Docetaxel—ovarian cancer	0.000411	0.00363	CcSEcCtD
SIMEPREVIR—Asthenia—Paclitaxel—ovarian cancer	0.000407	0.00359	CcSEcCtD
SIMEPREVIR—Pruritus—Paclitaxel—ovarian cancer	0.000401	0.00354	CcSEcCtD
SIMEPREVIR—ABCB1—testis—ovarian cancer	0.000395	0.0075	CbGeAlD
SIMEPREVIR—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000381	0.00336	CcSEcCtD
SIMEPREVIR—Anaemia—Epirubicin—ovarian cancer	0.000367	0.00324	CcSEcCtD
SIMEPREVIR—Rash—Paclitaxel—ovarian cancer	0.000358	0.00315	CcSEcCtD
SIMEPREVIR—Dermatitis—Paclitaxel—ovarian cancer	0.000357	0.00315	CcSEcCtD
SIMEPREVIR—Headache—Paclitaxel—ovarian cancer	0.000355	0.00313	CcSEcCtD
SIMEPREVIR—Asthenia—Docetaxel—ovarian cancer	0.000345	0.00304	CcSEcCtD
SIMEPREVIR—Pruritus—Docetaxel—ovarian cancer	0.00034	0.003	CcSEcCtD
SIMEPREVIR—Anaemia—Doxorubicin—ovarian cancer	0.00034	0.003	CcSEcCtD
SIMEPREVIR—Myalgia—Epirubicin—ovarian cancer	0.000338	0.00298	CcSEcCtD
SIMEPREVIR—Nausea—Paclitaxel—ovarian cancer	0.000337	0.00297	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000336	0.00296	CcSEcCtD
SIMEPREVIR—Infection—Epirubicin—ovarian cancer	0.000322	0.00284	CcSEcCtD
SIMEPREVIR—Skin disorder—Epirubicin—ovarian cancer	0.000315	0.00278	CcSEcCtD
SIMEPREVIR—Myalgia—Doxorubicin—ovarian cancer	0.000313	0.00276	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000311	0.00274	CcSEcCtD
SIMEPREVIR—Rash—Docetaxel—ovarian cancer	0.000303	0.00267	CcSEcCtD
SIMEPREVIR—Dermatitis—Docetaxel—ovarian cancer	0.000303	0.00267	CcSEcCtD
SIMEPREVIR—Headache—Docetaxel—ovarian cancer	0.000301	0.00266	CcSEcCtD
SIMEPREVIR—Infection—Doxorubicin—ovarian cancer	0.000298	0.00263	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000295	0.00261	CcSEcCtD
SIMEPREVIR—Insomnia—Epirubicin—ovarian cancer	0.000293	0.00259	CcSEcCtD
SIMEPREVIR—Skin disorder—Doxorubicin—ovarian cancer	0.000291	0.00257	CcSEcCtD
SIMEPREVIR—Dyspnoea—Epirubicin—ovarian cancer	0.000289	0.00255	CcSEcCtD
SIMEPREVIR—ABCB1—lymph node—ovarian cancer	0.000286	0.00543	CbGeAlD
SIMEPREVIR—Nausea—Docetaxel—ovarian cancer	0.000286	0.00252	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00028	0.00247	CcSEcCtD
SIMEPREVIR—Fatigue—Epirubicin—ovarian cancer	0.00028	0.00247	CcSEcCtD
SIMEPREVIR—Constipation—Epirubicin—ovarian cancer	0.000277	0.00245	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000273	0.00241	CcSEcCtD
SIMEPREVIR—Insomnia—Doxorubicin—ovarian cancer	0.000271	0.00239	CcSEcCtD
SIMEPREVIR—Dyspnoea—Doxorubicin—ovarian cancer	0.000268	0.00236	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000259	0.00228	CcSEcCtD
SIMEPREVIR—Fatigue—Doxorubicin—ovarian cancer	0.000259	0.00228	CcSEcCtD
SIMEPREVIR—Constipation—Doxorubicin—ovarian cancer	0.000257	0.00226	CcSEcCtD
SIMEPREVIR—Asthenia—Epirubicin—ovarian cancer	0.000233	0.00205	CcSEcCtD
SIMEPREVIR—Pruritus—Epirubicin—ovarian cancer	0.000229	0.00202	CcSEcCtD
SIMEPREVIR—Asthenia—Doxorubicin—ovarian cancer	0.000215	0.0019	CcSEcCtD
SIMEPREVIR—Pruritus—Doxorubicin—ovarian cancer	0.000212	0.00187	CcSEcCtD
SIMEPREVIR—Rash—Epirubicin—ovarian cancer	0.000204	0.0018	CcSEcCtD
SIMEPREVIR—Dermatitis—Epirubicin—ovarian cancer	0.000204	0.0018	CcSEcCtD
SIMEPREVIR—Headache—Epirubicin—ovarian cancer	0.000203	0.00179	CcSEcCtD
SIMEPREVIR—Nausea—Epirubicin—ovarian cancer	0.000193	0.0017	CcSEcCtD
SIMEPREVIR—Rash—Doxorubicin—ovarian cancer	0.000189	0.00167	CcSEcCtD
SIMEPREVIR—Dermatitis—Doxorubicin—ovarian cancer	0.000189	0.00167	CcSEcCtD
SIMEPREVIR—Headache—Doxorubicin—ovarian cancer	0.000188	0.00166	CcSEcCtD
SIMEPREVIR—Nausea—Doxorubicin—ovarian cancer	0.000178	0.00157	CcSEcCtD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	4.34e-05	0.00192	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—PTEN—ovarian cancer	4.26e-05	0.00189	CbGpPWpGaD
SIMEPREVIR—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	4.19e-05	0.00186	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—AQP3—ovarian cancer	4.18e-05	0.00186	CbGpPWpGaD
SIMEPREVIR—ALB—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	4.16e-05	0.00185	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.14e-05	0.00184	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—PTEN—ovarian cancer	4.09e-05	0.00181	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—TLR4—ovarian cancer	4.06e-05	0.0018	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	4.06e-05	0.0018	CbGpPWpGaD
SIMEPREVIR—ALB—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	4.02e-05	0.00178	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—ATP7B—ovarian cancer	4.01e-05	0.00178	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.96e-05	0.00176	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	3.91e-05	0.00174	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IL6ST—ovarian cancer	3.9e-05	0.00173	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	3.83e-05	0.0017	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	3.83e-05	0.0017	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—NRAS—ovarian cancer	3.8e-05	0.00168	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	3.78e-05	0.00168	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	3.75e-05	0.00166	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.7e-05	0.00164	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	3.7e-05	0.00164	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CYTB—ovarian cancer	3.69e-05	0.00164	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	3.68e-05	0.00163	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	3.67e-05	0.00163	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—CASP3—ovarian cancer	3.66e-05	0.00163	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IL2—ovarian cancer	3.66e-05	0.00162	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—NRAS—ovarian cancer	3.65e-05	0.00162	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—MAPK3—ovarian cancer	3.64e-05	0.00161	CbGpPWpGaD
SIMEPREVIR—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	3.62e-05	0.0016	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.61e-05	0.0016	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	3.59e-05	0.00159	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.58e-05	0.00159	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	3.56e-05	0.00158	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	3.52e-05	0.00156	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	3.51e-05	0.00156	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet degranulation—VEGFA—ovarian cancer	3.51e-05	0.00156	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	3.5e-05	0.00155	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	3.48e-05	0.00155	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—MAPK1—ovarian cancer	3.46e-05	0.00154	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—EGFR—ovarian cancer	3.46e-05	0.00154	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CDH1—ovarian cancer	3.45e-05	0.00153	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	3.44e-05	0.00153	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	3.44e-05	0.00153	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	3.44e-05	0.00153	CbGpPWpGaD
SIMEPREVIR—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	3.35e-05	0.00149	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—EGFR—ovarian cancer	3.32e-05	0.00147	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—PIK3CD—ovarian cancer	3.29e-05	0.00146	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NME2—ovarian cancer	3.27e-05	0.00145	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—KRAS—ovarian cancer	3.27e-05	0.00145	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	3.25e-05	0.00144	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—BRIP1—ovarian cancer	3.22e-05	0.00143	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PPP1CC—ovarian cancer	3.22e-05	0.00143	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.17e-05	0.00141	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—KRAS—ovarian cancer	3.14e-05	0.00139	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	3.11e-05	0.00138	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—TP53—ovarian cancer	3.1e-05	0.00137	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—PIK3CA—ovarian cancer	3e-05	0.00133	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—ERBB2—ovarian cancer	2.91e-05	0.00129	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.9e-05	0.00128	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.89e-05	0.00128	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—PIK3CA—ovarian cancer	2.88e-05	0.00128	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—MTOR—ovarian cancer	2.87e-05	0.00127	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—PIK3CB—ovarian cancer	2.87e-05	0.00127	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NME2—ovarian cancer	2.87e-05	0.00127	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.86e-05	0.00127	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—IL6—ovarian cancer	2.83e-05	0.00126	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.82e-05	0.00125	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—HRAS—ovarian cancer	2.78e-05	0.00123	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.78e-05	0.00123	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—SPARC—ovarian cancer	2.78e-05	0.00123	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.77e-05	0.00123	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	2.76e-05	0.00123	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.71e-05	0.0012	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CDKN1B—ovarian cancer	2.69e-05	0.00119	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—HRAS—ovarian cancer	2.67e-05	0.00118	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—IL6—ovarian cancer	2.66e-05	0.00118	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IL2—ovarian cancer	2.63e-05	0.00117	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	2.61e-05	0.00116	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.57e-05	0.00114	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CTNNB1—ovarian cancer	2.54e-05	0.00113	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—PTEN—ovarian cancer	2.48e-05	0.0011	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—AKT1—ovarian cancer	2.45e-05	0.00109	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—AKT1—ovarian cancer	2.36e-05	0.00105	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.35e-05	0.00104	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2.29e-05	0.00102	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	2.29e-05	0.00102	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NME2—ovarian cancer	2.29e-05	0.00102	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.26e-05	0.001	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	2.25e-05	0.000999	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—STAT3—ovarian cancer	2.22e-05	0.000984	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—NRAS—ovarian cancer	2.21e-05	0.000981	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—YAP1—ovarian cancer	2.16e-05	0.00096	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.14e-05	0.00095	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—MAPK3—ovarian cancer	2.12e-05	0.00094	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.12e-05	0.000939	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYTB—ovarian cancer	2.11e-05	0.000935	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.06e-05	0.000914	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.04e-05	0.000907	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—SOD1—ovarian cancer	2.02e-05	0.000895	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—MAPK1—ovarian cancer	2.02e-05	0.000894	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—EGFR—ovarian cancer	2.02e-05	0.000894	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PPP2R1A—ovarian cancer	2.01e-05	0.00089	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	2e-05	0.000886	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.99e-05	0.000884	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.94e-05	0.000861	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—KRAS—ovarian cancer	1.9e-05	0.000845	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.88e-05	0.000835	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.85e-05	0.000822	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYTB—ovarian cancer	1.85e-05	0.000819	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.85e-05	0.000819	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—BRIP1—ovarian cancer	1.84e-05	0.000817	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PPP1CC—ovarian cancer	1.84e-05	0.000817	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	1.83e-05	0.000814	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.81e-05	0.000802	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.79e-05	0.000794	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NME2—ovarian cancer	1.77e-05	0.000783	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—FASN—ovarian cancer	1.76e-05	0.000782	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.76e-05	0.000781	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—PIK3CA—ovarian cancer	1.75e-05	0.000776	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.74e-05	0.000773	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	1.73e-05	0.000769	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.7e-05	0.000754	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	1.67e-05	0.000743	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.64e-05	0.000728	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—HRAS—ovarian cancer	1.62e-05	0.000718	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—BRIP1—ovarian cancer	1.61e-05	0.000716	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.61e-05	0.000716	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.61e-05	0.000716	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	1.61e-05	0.000712	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.58e-05	0.000702	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.56e-05	0.000691	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IL6—ovarian cancer	1.55e-05	0.000687	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.53e-05	0.000681	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—CAV1—ovarian cancer	1.47e-05	0.000654	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYTB—ovarian cancer	1.47e-05	0.000654	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.47e-05	0.000654	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.45e-05	0.000644	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.44e-05	0.000639	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—AKT1—ovarian cancer	1.43e-05	0.000634	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	1.42e-05	0.000632	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.42e-05	0.000629	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.41e-05	0.000626	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.4e-05	0.000622	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.38e-05	0.000613	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.38e-05	0.000613	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3CG—ovarian cancer	1.34e-05	0.000596	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.34e-05	0.000596	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—ABCB1—ovarian cancer	1.32e-05	0.000587	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.3e-05	0.000579	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—TYMS—ovarian cancer	1.3e-05	0.000576	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.29e-05	0.000572	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.29e-05	0.000572	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—YAP1—ovarian cancer	1.24e-05	0.000548	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.22e-05	0.000543	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.22e-05	0.00054	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.2e-05	0.000532	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3CD—ovarian cancer	1.18e-05	0.000524	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.16e-05	0.000514	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYTB—ovarian cancer	1.14e-05	0.000505	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—YAP1—ovarian cancer	1.08e-05	0.00048	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.08e-05	0.000477	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CAV1—ovarian cancer	1.05e-05	0.000464	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3CB—ovarian cancer	1.03e-05	0.000457	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—FASN—ovarian cancer	1.01e-05	0.000447	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1e-05	0.000444	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PPP1CC—ovarian cancer	9.95e-06	0.000441	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—BRIP1—ovarian cancer	9.95e-06	0.000441	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	9.94e-06	0.000441	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—SLC5A5—ovarian cancer	9.91e-06	0.00044	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	9.79e-06	0.000434	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—SLC2A1—ovarian cancer	9.57e-06	0.000425	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	9.53e-06	0.000423	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—IL2—ovarian cancer	9.45e-06	0.000419	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.39e-06	0.000417	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.37e-06	0.000416	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP1B1—ovarian cancer	9.17e-06	0.000407	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—FASN—ovarian cancer	8.83e-06	0.000392	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—SLC5A5—ovarian cancer	8.68e-06	0.000385	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—YAP1—ovarian cancer	8.64e-06	0.000383	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.55e-06	0.00038	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—SLC2A1—ovarian cancer	8.38e-06	0.000372	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	8.38e-06	0.000372	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PPP2R1A—ovarian cancer	8.14e-06	0.000361	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.1e-06	0.000359	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP1B1—ovarian cancer	8.04e-06	0.000357	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—VEGFA—ovarian cancer	8.03e-06	0.000356	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—NRAS—ovarian cancer	7.93e-06	0.000352	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—MAPK3—ovarian cancer	7.6e-06	0.000337	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ABCB1—ovarian cancer	7.56e-06	0.000335	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.52e-06	0.000334	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—TYMS—ovarian cancer	7.42e-06	0.000329	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	7.3e-06	0.000324	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—MAPK1—ovarian cancer	7.23e-06	0.000321	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PPP2R1A—ovarian cancer	7.13e-06	0.000316	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—FASN—ovarian cancer	7.05e-06	0.000313	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SLC5A5—ovarian cancer	6.93e-06	0.000307	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—KRAS—ovarian cancer	6.83e-06	0.000303	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SLC2A1—ovarian cancer	6.69e-06	0.000297	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—YAP1—ovarian cancer	6.67e-06	0.000296	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.55e-06	0.000291	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—TYMS—ovarian cancer	6.5e-06	0.000288	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP1B1—ovarian cancer	6.42e-06	0.000285	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PTEN—ovarian cancer	6.31e-06	0.00028	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3CA—ovarian cancer	6.27e-06	0.000278	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TP53—ovarian cancer	6.07e-06	0.000269	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CAV1—ovarian cancer	5.98e-06	0.000265	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—HRAS—ovarian cancer	5.81e-06	0.000258	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.71e-06	0.000253	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	5.69e-06	0.000253	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.66e-06	0.000251	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CG—ovarian cancer	5.45e-06	0.000242	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—FASN—ovarian cancer	5.44e-06	0.000241	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.35e-06	0.000237	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ABCB1—ovarian cancer	5.28e-06	0.000234	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CAV1—ovarian cancer	5.24e-06	0.000232	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—TYMS—ovarian cancer	5.19e-06	0.00023	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.17e-06	0.000229	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—AKT1—ovarian cancer	5.13e-06	0.000227	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.95e-06	0.00022	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CD—ovarian cancer	4.79e-06	0.000212	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.77e-06	0.000212	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	4.45e-06	0.000198	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.39e-06	0.000195	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CD—ovarian cancer	4.19e-06	0.000186	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CAV1—ovarian cancer	4.18e-06	0.000186	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CB—ovarian cancer	4.17e-06	0.000185	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.08e-06	0.000181	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—TYMS—ovarian cancer	4.01e-06	0.000178	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4e-06	0.000177	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CG—ovarian cancer	3.81e-06	0.000169	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.66e-06	0.000162	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—AKT1—ovarian cancer	3.64e-06	0.000161	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PTEN—ovarian cancer	3.61e-06	0.00016	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CD—ovarian cancer	3.35e-06	0.000149	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CAV1—ovarian cancer	3.23e-06	0.000143	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PTEN—ovarian cancer	3.16e-06	0.00014	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.94e-06	0.00013	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.92e-06	0.00013	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.58e-06	0.000115	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CA—ovarian cancer	2.54e-06	0.000113	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PTEN—ovarian cancer	2.52e-06	0.000112	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.25e-06	9.99e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.23e-06	9.89e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—AKT1—ovarian cancer	2.08e-06	9.22e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PTEN—ovarian cancer	1.95e-06	8.64e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—AKT1—ovarian cancer	1.82e-06	8.08e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.78e-06	7.89e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—AKT1—ovarian cancer	1.45e-06	6.45e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.37e-06	6.09e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—AKT1—ovarian cancer	1.12e-06	4.98e-05	CbGpPWpGaD
